pr-inside.com
Print
Indevus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Indevus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released



companiesandmarkets.com
2009-11-10 00:05:01 - Indevus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/indevus-phar ..

Indevus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Indevus Pharmaceuticals, Inc. (Indevus), a specialty pharmaceutical company, is engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The company has four major product namely SANCTURA and SANCTURA XR for overactive bladder (OAB); VANTAS for advanced prostate cancer; SUPPRELIN LA for central

 

 

precocious puberty (CPP), and DELATESTRYL for the treatment of hypogonadism. Its pipeline product includes VALSTAR for bladder cancer, NEBIDO for hypogonadism, PRO 2000 for the prevention of infection by human immunodeficiency virus (HIV) and other sexually transmitted diseases.

The Indevus Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.

Author:
Mike King
e-mail
Web: http://www.companiesandmarkets.com
Telefon: London: +44 (0) 203 086 8600




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.